SEC Form 4 · accession 0001013606-18-000082
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Director
Period of report
May 28, 2018
Accepted (ET)
May 30, 2018 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 28, 2018 | A | 48,222 | $0.00 | A | 886,709 | D | |
| Common StockF2 | May 29, 2018 | F | 7,286 | $5.65 | D | 879,423 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on June 1, 2015. 33% of the shares subject to this restricted stock award vested pursuant to the terms of this award.
- F2Shares withheld on May 29, 2018 to satisfy statutory minimum tax withholding obligations related to shares vested on May 28, 2018.